A phase II multicenter trial with Rivaroxaban in the treatment of livedoid vasculopathy assessing the pain on a visual analog scal (VAS)
Basic data for this project
Type of project: Individual project
Duration at the University of Münster: 01/12/2011 - 30/06/2015
Description
Keywords: Studie; Livedoid Vasculopathy
Funding identifier: Xarelto
Funder / funding scheme:
- Bayer Vital GmbH
Project management at the University of Münster
| Görge, Tobias | Clinic for Dermatology |
Applicants from the University of Münster
| Görge, Tobias | Clinic for Dermatology |
Research associates from the University of Münster
| Eveslage, Maria | Institute of Biostatistics and Clinical Research (IBKF) |
| Faldum, Andreas | Center of Clinical Trials (ZKS) |
| Gerß, Joachim | Institute of Biostatistics and Clinical Research (IBKF) |
| Urban, Marc | Center of Clinical Trials (ZKS) |